Rating Change
Ascendiant Capital reiterated its Buy rating on Alzamend Neuro, Inc. (NASDAQ:ALZN) on August 19, 2026.
reiterateNASDAQ:ALZN
Ascendiant Capital Reiterates Buy Rating on Alzamend Neuro, Inc. (ALZN)
Ascendiant Capital reiterated its Buy rating on Alzamend Neuro, Inc. (NASDAQ:ALZN) on August 19, 2026.
At publication ·
What changed
Alzamend Neuro, Inc. (NASDAQ:ALZN) · reiterate
- Firm
- Ascendiant Capital
- Rating
- Buy to Buy
- Price at event
- $1.52
- Market capitalization
- $6.3M
At a glance
Key takeaways
- Ascendiant Capital reiterated its Buy rating on Alzamend Neuro (NASDAQ:ALZN) on August 19, 2026, with the stock trading at $1.52 and a market capitalization of $6.3 million.
Market Context
Alzamend Neuro, Inc. operates in the Healthcare sector. The stock currently trades at $1.52 with a market capitalization of $6.3M.
Analyst coverage from Ascendiant Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Alzamend Neuro, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Alzamend Neuro, Inc.
Among the 9 most recent ratings: 9 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 19, 2026 | Ascendiant Capital | Buy | N/A |
| Dec 22, 2025 | Ascendiant Capital | Buy | N/A |
| Sep 25, 2025 | Ascendiant Capital | Buy | N/A |
| Aug 21, 2025 | Ascendiant Capital | Buy | N/A |
| Mar 17, 2025 | Ascendiant Capital | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ALZN Stock Page
Frequently Asked Questions
What does the Buy rating mean for ALZN?
A rating of Buy from Ascendiant Capital reflects the analyst's outlook on Alzamend Neuro, Inc. (NASDAQ:ALZN). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ALZN forecast page.